Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Ambrisentan Tablets, 5 mg and 10 mg.
from The Medical News http://ift.tt/1GXPmzQ
from The Medical News http://ift.tt/1GXPmzQ
No comments:
Post a Comment